According to the China Finance and Economics app, Yimai Yangguang (02522) rose more than 19%, hitting a new high of 23.2 Hong Kong dollars, up more than 54% from the IPO price of 14.98 Hong Kong dollars. As of press time, it had risen 18.37% to 22.75 Hong Kong dollars, with a turnover of 11.1282 million Hong Kong dollars.

As the leading enterprise in the domestic medical imaging field, Yimai Yangguang operates a total of 97 imaging centers throughout the country. The prospectus shows that in 2021, 2022 and 2023, Yimai Yangguang's revenue will be 592 million yuan, 784 million yuan and 929 million yuan, with a compound annual growth rate of 25.3%. Meanwhile, the company's profitability is also increasing year by year. It is expected to turn losses into profits in 2023, with an adjusted net profit of 59,996,000 yuan.

In addition, according to the latest data, as of May 2, 2024, the market capitalization threshold for Hong Kong-listed companies to enter the Hong Kong Stock Connect is about HKD 5.705 billion. As of now, the average daily turnover market capitalization of Yimai Yangguang's H shares is approximately HKD 4 billion. Goldman Sachs previously mentioned that it is bullish on Yimai Yangguang's business model combining offline imaging centers and online imaging cloud computing services, as well as the team's rich experience in medical imaging equipment sales and operation management, and continues to be optimistic about China's third-party imaging center industry.